Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +33.64%
#3 Cysic Cysic +24.17%
#4 Nockchain Nockchain +18.65%
#5 Velvet Velvet +18.00%
#6 Nillion Nillion +13.02%
#7 FOLKS FOLKS +12.57%
#8 Versatize Coin Versatize Coin +12.49%
#9 Humanity Humanity +11.40%
#10 Bedrock Bedrock +10.87%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Erech Finance Cahalacha Ltd Erech Finance Cahalacha Ltd

Erech Finance Cahalacha Ltd

EFNC
Rank in Stocks #37366
Erech Finance Cahalacha Ltd, including its subsidiaries, provides diverse... Erech Finance Cahalacha Ltd, including its subsidiaries, provides diverse lending and credit solutions to small and medium-sized businesses, associations, and individual clients across Israel. The company's operations are structured into two main divisions: Non-Bank Credit and Biomed Drug. Additionally, Erech Finance Cahalacha Ltd is engaged in pharmaceutical research and development, concentrating on treatments for diabetes and cancer. Its corporate headquarters are located in Jerusalem, Israel.
Share Price
$0.703043
Last synced: 2024-08-19
Market Cap
$1.78M
Change (1 day)
-1.18%
Change (1 year)
0.00%
Country
IL
Trade Erech Finance Cahalacha Ltd (EFNC)

Category

Healthcare
Revenue for Erech Finance Cahalacha Ltd (EFNC)
Revenue in Aug 2026 TTM: 0
According to Erech Finance Cahalacha Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Erech Finance Cahalacha Ltd from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US